|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net income | ||||
| Net investment (gains) losses | ||||
| Depreciation and amortization expense | ||||
| Stock-based compensation expense | ||||
| Unrealized losses on investment in Westaim | ||||
| Undistributed earnings (loss) from long-term investments | ||||
| Net change in fair value of derivatives | ||||
| Deferred income tax, net | ||||
| Premiums receivable, net | ||||
| Reinsurance recoverables, net | ||||
| Ceded unearned premium | ||||
| Deferred policy acquisition costs | ||||
| Federal income taxes | ||||
| Losses and loss adjustment expenses | ||||
| Unearned premiums | ||||
| Deferred ceding commission | ||||
| Reinsurance and premium payables | ||||
| Funds held for others | ||||
| Accounts payable and accrued liabilities | ||||
| Other, net | ||||
| Net cash provided by operating activities | ||||
| Cash flows from investing activities: | ||||
| Purchase of fixed maturity securities, available-for-sale | ||||
| Purchase of illiquid investments | ||||
| Purchase of equity securities | ||||
| Purchase of equity method investments and other long-term investments | ||||
| Purchase of intangible assets and goodwill | ||||
| Investment in direct and indirect loans | ||||
| Purchase of property and equipment | ||||
| Proceeds from the sales of fixed maturity securities, available-for-sale | ||||
| Maturities, calls, transfers and paydowns of fixed maturity securities, available-for-sale | ||||
| Maturities, calls and paydowns of fixed maturity securities held-to-maturity | ||||
| Proceeds from the sales of equity securities | ||||
| Sales of and distributions from equity method and other long-term investments | ||||
| Change in short-term investments | ||||
| Change in receivable/payable for securities | ||||
| Cash provided by deposit accounting | ||||
| Net cash used in investment activities | ||||
| Cash flows from financing activities: | ||||
| Employee share purchases | ||||
| Repayment of stock notes receivable | ||||
| Proceeds from long term borrowings | ||||
| Payments on long term borrowings and trust preferred | ||||
| Proceeds from equity offerings | ||||
| Proceeds from employee stock purchase plan | ||||
| Proceeds from initial public offering | ||||
| Net cash provided by (used in) financing activities | ||||
| Net increase (decrease) in cash and cash equivalents and restricted cash | ||||
| Cash and cash equivalents and restricted cash at beginning of period | ||||
| Cash and cash equivalents and restricted cash at end of period | ||||
| Supplemental disclosure of cash flow information: | ||||
| Cash paid for interest | ||||
| Cash paid for federal income taxes | ||||
Loading...
